These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37622487)

  • 1. Opioid Use Disorder Stigma and Support for Harm Reduction in Rural Counties.
    Whipple CR; Kaynak Ö; Kruis NE; Saylor E; Bonnevie E; Kensinger WS
    Subst Use Misuse; 2023; 58(14):1818-1828. PubMed ID: 37622487
    [No Abstract]   [Full Text] [Related]  

  • 2. Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study.
    Davis A; Stringer KL; Drainoni ML; Oser CB; Knudsen HK; Aldrich A; Surratt HL; Walker DM; Gilbert L; Downey DL; Gardner SD; Tan S; Lines LM; Vandergrift N; Mack N; Holloway J; Lunze K; McAlearney AS; Huerta TR; Goddard-Eckrich DA; El-Bassel N
    Int J Drug Policy; 2023 Dec; 122():104241. PubMed ID: 37890391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community.
    Heo M; Beachler T; Sivaraj LB; Tsai HL; Chea A; Patel A; Litwin AH; Zeller TA
    Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):23. PubMed ID: 37076898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes toward syringe exchange programs in a rural Appalachian community.
    Zeller TA; Beachler T; Diaz L; Thomas RP; Heo M; Lanzillotta-Rangeley J; Litwin AH
    J Addict Dis; 2022; 40(2):227-234. PubMed ID: 34550054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community Attitudes Toward Opioid Use Disorder and Medication for Opioid Use Disorder in a Rural Appalachian County.
    Beachler T; Zeller TA; Heo M; Lanzillotta-Rangeley J; Litwin AH
    J Rural Health; 2021 Jan; 37(1):29-34. PubMed ID: 32738095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Opioid Epidemic and the State of Stigma: A Pennsylvania Statewide Survey.
    Kaynak Ö; Whipple CR; Bonnevie E; Grossman JA; Saylor EM; Stefanko M; McKeon C; Smyser J; Kensinger WS
    Subst Use Misuse; 2022; 57(7):1120-1130. PubMed ID: 35459425
    [No Abstract]   [Full Text] [Related]  

  • 7. First Responders' Views of Naloxone: Does Stigma Matter?
    Kruis NE; McLean K; Perry P; Nackley MK
    Subst Use Misuse; 2022; 57(10):1534-1544. PubMed ID: 35791871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Support for evidence-informed opioid policies and interventions: The role of racial attitudes, political affiliation, and opioid stigma.
    Pyra M; Taylor B; Flanagan E; Hotton A; Johnson O; Lamuda P; Schneider J; Pollack HA
    Prev Med; 2022 May; 158():107034. PubMed ID: 35339585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engagement in Harm Reduction Strategies After Suspected Fentanyl Contamination Among Opioid-Dependent Individuals.
    Mistler CB; Chandra DK; Copenhaver MM; Wickersham JA; Shrestha R
    J Community Health; 2021 Apr; 46(2):349-357. PubMed ID: 32997253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A National Portrait of Public Attitudes toward Opioid Use in the US: A Latent Class Analysis.
    Walters SM; Liu W; Lamuda P; Huh J; Brewer R; Johnson O; Bluthenthal RN; Taylor B; Schneider JA
    Int J Environ Res Public Health; 2023 Mar; 20(5):. PubMed ID: 36901465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments.
    Sasson C; Dieujuste N; Klocko R; Basrai Z; Celedon M; Hsiao J; Himstreet J; Hoffman J; Pfaff C; Malmstrom R; Smith J; Holstein A; Johnson-Koenke R
    Acad Emerg Med; 2023 Apr; 30(4):289-298. PubMed ID: 36757683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic.
    McGinty EE; Barry CL; Stone EM; Niederdeppe J; Kennedy-Hendricks A; Linden S; Sherman SG
    Prev Med; 2018 Jun; 111():73-77. PubMed ID: 29481827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Social Stigma toward Persons with Opioid Use Disorder: Results from a Nationally Representative Survey of U.S. Adults.
    Taylor BG; Lamuda PA; Flanagan E; Watts E; Pollack H; Schneider J
    Subst Use Misuse; 2021; 56(12):1752-1764. PubMed ID: 34315335
    [No Abstract]   [Full Text] [Related]  

  • 14. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities.
    Ezell JM; Walters S; Friedman SR; Bolinski R; Jenkins WD; Schneider J; Link B; Pho MT
    Soc Sci Med; 2021 Jan; 268():113470. PubMed ID: 33253992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
    Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
    J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences.
    Brown AR; Walters JE; Harmer B; Cates L; Jones AE
    J Subst Use Addict Treat; 2023 Dec; 155():209153. PubMed ID: 37673286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use and opioid-related stigma among Black communities in the rural South.
    Cody SL; Newman S; Bui C; Sharp-Marbury R; Scott L
    Arch Psychiatr Nurs; 2023 Oct; 46():127-132. PubMed ID: 37813495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "I wouldn't need Narcan for myself, but I can have it for somebody else:" perceptions of harm reduction among hospitalized patients with OUD.
    French R; Holliday Davis M; Aronowitz SV; Crowe M; Abrams M; Edwards G; Lowenstein M
    Addict Sci Clin Pract; 2023 Jun; 18(1):41. PubMed ID: 37355639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study.
    Perry BL; Pescosolido BA; Krendl AC
    Addiction; 2020 Dec; 115(12):2317-2326. PubMed ID: 32219910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.